Literature DB >> 27596219

[Treatment of low-risk pediatric lymphocyte-predominant Hodgkin lymphoma].

Georg Mann1, Wolfgang Holter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27596219     DOI： 10.1007/s00066-016-1044-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

1.  The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).

Authors:  Sylvia Hartmann; Dennis A Eichenauer; Annette Plütschow; Anja Mottok; Roshanak Bob; Karoline Koch; Heinz-Wolfram Bernd; Sergio Cogliatti; Michael Hummel; Alfred C Feller; German Ott; Peter Möller; Andreas Rosenwald; Harald Stein; Martin-Leo Hansmann; Andreas Engert; Wolfram Klapper
Journal:  Blood       Date:  2013-10-07       Impact factor: 22.113

2.  Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

Authors:  Christine Mauz-Körholz; Dirk Hasenclever; Wolfgang Dörffel; Kathrin Ruschke; Tanja Pelz; Antje Voigt; Martina Stiefel; Melanie Winkler; Constanze Vilser; Karin Dieckmann; Jonas Karlén; Eva Bergsträsser; Alexander Fosså; Georg Mann; Michael Hummel; Wolfram Klapper; Harald Stein; Dirk Vordermark; Regine Kluge; Dieter Körholz
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

3.  Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.

Authors:  Zhen Fan; Yasodha Natkunam; Eric Bair; Robert Tibshirani; Roger A Warnke
Journal:  Am J Surg Pathol       Date:  2003-10       Impact factor: 6.394

4.  Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Authors:  Ludmila Boudová; Emina Torlakovic; Jan Delabie; Peter Reimer; Beate Pfistner; Sabine Wiedenmann; Volker Diehl; Hans-Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.

Authors:  Burton E Appel; Lu Chen; Allen B Buxton; Robert E Hutchison; David C Hodgson; Peter F Ehrlich; Louis S Constine; Cindy L Schwartz
Journal:  J Clin Oncol       Date:  2016-05-16       Impact factor: 44.544

7.  Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group.

Authors:  Ananth G Shankar; Amy A Kirkwood; Sarita Depani; Eleonora Bianchi; Janis Hayward; Alan D Ramsay; Georgina W Hall
Journal:  Br J Haematol       Date:  2016-03-21       Impact factor: 6.998

8.  Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Ranjana H Advani; Sandra J Horning; Richard T Hoppe; Sarah Daadi; John Allen; Yasodha Natkunam; Nancy L Bartlett
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

9.  Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

Authors:  Wolfgang Dörffel; Ursula Rühl; Heike Lüders; Alexander Claviez; Marion Albrecht; Jos Bökkerink; Harald Holte; Jonas Karlen; Georg Mann; Heinz Marciniak; Felix Niggli; Kjeld Schmiegelow; Ernst-Wilhelm Schwarze; Richard Pötter; Lutz Wickmann; Günther Schellong
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544

10.  Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.

Authors:  Christine Mauz-Körholz; Stephanie Gorde-Grosjean; Dirk Hasenclever; Ananth Shankar; Wolfgang Dörffel; W Hamish Wallace; Günther Schellong; Alain Robert; Dieter Körholz; Odile Oberlin; Georgina W Hall; Judith Landman-Parker
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.